Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.

Structural changes of the androgen receptor (AR) may contribute to the development of resistance to endocrine therapy in prostatic carcinoma. We have isolated AR cDNA fragments from seven tumor specimens derived from patients with advanced metastatic prostatic tumors. In one specimen obtained from a...

Full description

Saved in:
Bibliographic Details
Main Authors: Zoran Čulig, Alfred Hobisch, Marcus V. Cronauer, Andrew C.B. Cato, A Hittmair, Christian Radmayr, Julia Eberle, G. Bartsch, Helmut Klocker
Format: Artigo
Language:English
Published: 1993
Online Access:https://doi.org/10.1210/mend.7.12.8145761
https://academic.oup.com/mend/article-pdf/7/12/1541/9079613/mend1541.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!